Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2012 |  NVAX Novavax, Inc. - Common Stock | 11.01 USD | -1.87% | +2.32% | +9.55% | +23.43% | 1.82 B USD | ||
| 2019 |  URGN UroGen Pharma Ltd. - Ordinary Shares | 36.98 USD | -9.14% | -9.65% | -15.61% | +94.63% | 1.81 B USD | ||
| 2022 |  BHVN Biohaven Ltd. Common Shares | 11.94 USD | +0.34% | -10.70% | -17.66% | -29.52% | 1.80 B USD | ||
| 2027 |  ZYME Zymeworks Inc. - Common Stock | 25.26 USD | -4.79% | -2.77% | -9.17% | +42.39% | 1.79 B USD | ||
| 2031 |  MESO Mesoblast Limited - American Depositary Shares | 13.75 USD | -1.36% | -4.11% | -15.38% | -30.38% | 1.78 B USD | ||
| 2039 |  NTLA Intellia Therapeutics, Inc. - Common Stock | 12.60 USD | +7.60% | +1.45% | +0.80% | -8.16% | 1.77 B USD | ||
| 2046 |  NUVB Nuvation Bio Inc. Class A Common Stock | 4.98 USD | +2.26% | -12.01% | -23.74% | +33.87% | 1.75 B USD | ||
| 2053 |  SEPN Septerna, Inc. - Common Stock | 36.90 USD | +2.50% | -4.99% | -0.67% | +67.65% | 1.72 B USD | ||
| 2060 |  ZBIO Zenas BioPharma, Inc. - Common Stock | 26.24 USD | -6.88% | -7.83% | -20.53% | -0.83% | 1.71 B USD | ||
| 2087 |  OCUL Ocular Therapeutix, Inc. - Common Stock | 7.51 USD | +3.87% | +1.21% | -33.19% | -34.70% | 1.65 B USD | ||
| 2121 |  QURE uniQure N.V. - Ordinary Shares | 22.54 USD | -2.59% | -4.97% | -50.69% | -62.35% | 1.56 B USD | ||
| 2126 |  STOK Stoke Therapeutics, Inc. - Common Stock | 23.95 USD | -1.40% | -9.04% | -18.90% | -21.22% | 1.55 B USD | ||
| 2130 |  ABSI Absci Corporation - Common Stock | 8.94 USD | -3.04% | -19.75% | +0.56% | +115.42% | 1.53 B USD | ||
| 2143 |  SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 16.90 USD | -0.76% | -8.45% | -14.73% | +2.36% | 1.51 B USD | ||
| 2144 |  INVA Innoviva, Inc. - Common Stock | 20.87 USD | -0.90% | +1.31% | -1.37% | +17.12% | 1.51 B USD | ||
| 2145 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 15.29 USD | +2.69% | +2.62% | +3.59% | -50.69% | 1.51 B USD | ||
| 2152 |  IMCR Immunocore Holdings plc - American Depositary Shares | 29.09 USD | -1.09% | -5.49% | -17.26% | -13.11% | 1.50 B USD | ||
| 2165 |  TSHA Taysha Gene Therapies, Inc. - Common Stock | 4.43 USD | 0.00% | -7.71% | -17.96% | -12.45% | 1.44 B USD | ||
| 2192 |  NKTR Nektar Therapeutics - Common Stock | 40.80 USD | +1.34% | -11.78% | -45.67% | -44.32% | 1.39 B USD | ||
| 2198 |  OMER Omeros Corporation - Common Stock | 19.12 USD | +1.97% | +2.80% | +0.58% | +331.60% | 1.38 B USD |
Notícias Biotechnology Stocks
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Quantum-Si detecta 19 aminoácidos no programa de desenvolvimento Proteus
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |